- Home
- DCTH vs TLRY Comparison
DCTH vs TLRY Comparison
Compare DCTH & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- TLRY
- Stock Information
- Founded
- DCTH 1988
- TLRY N/A
- Country
- DCTH United States
- TLRY Canada
- Employees
- DCTH 76
- TLRY N/A
- Industry
- DCTH Medical/Dental Instruments
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- DCTH Health Care
- TLRY Health Care
- Exchange
- DCTH Nasdaq
- TLRY Nasdaq
- Market Cap
- DCTH 426.3M
- TLRY 426.2M
- IPO Year
- DCTH N/A
- TLRY 2018
- Fundamental
- Price
- DCTH $11.52
- TLRY $0.60
- Analyst Decision
- DCTH Strong Buy
- TLRY Hold
- Analyst Count
- DCTH 4
- TLRY 2
- Target Price
- DCTH $24.00
- TLRY $1.38
- AVG Volume (30 Days)
- DCTH 850.4K
- TLRY 36.6M
- Earning Date
- DCTH 08-04-2025
- TLRY 07-28-2025
- Dividend Yield
- DCTH N/A
- TLRY N/A
- EPS Growth
- DCTH N/A
- TLRY N/A
- EPS
- DCTH N/A
- TLRY N/A
- Revenue
- DCTH $53,850,000.00
- TLRY $826,656,000.00
- Revenue This Year
- DCTH $155.42
- TLRY $9.91
- Revenue Next Year
- DCTH $37.93
- TLRY $5.94
- P/E Ratio
- DCTH N/A
- TLRY N/A
- Revenue Growth
- DCTH 1068.87
- TLRY 11.22
- 52 Week Low
- DCTH $7.17
- TLRY $0.35
- 52 Week High
- DCTH $18.23
- TLRY $2.15
- Technical
- Relative Strength Index (RSI)
- DCTH 32.83
- TLRY 70.01
- Support Level
- DCTH $12.11
- TLRY $0.39
- Resistance Level
- DCTH $14.15
- TLRY $0.70
- Average True Range (ATR)
- DCTH 0.57
- TLRY 0.05
- MACD
- DCTH -0.16
- TLRY 0.03
- Stochastic Oscillator
- DCTH 9.67
- TLRY 82.89
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.